期刊文献+

荧光原位杂交检测BcR/ABL融合基因假阳性结果的校正 被引量:1

Calibration of false positive result in detection of BCR/ABL using fluorescence in situ hybridization
原文传递
导出
摘要 目的探讨荧光原位杂交(fluorescenceinsituhybridization,FISH)检测BCR/ABL融合基因时假阳性信号对结果的影响,并探讨校正结果的方法。方法将阴性标本与BCR/ABL双色双融合(dual—colordualfusion,DCDF)、探针信号表现为1红2绿1融合(1R2G1F)且额外信号(extrasignal,ES)探针信号表现为1红1绿1融合(1R1G1F)的阳性标本按不同比例混合,分别应用BCR/ABLDCDF探针及ES探针对不同比例混合的标本进行检测,并对不同的混合比例下DF探针检测的结果以及ES探针校正前后的结果与理论值使用二项分布进行对比。结果随着阴性细胞比例的增高,假阳性率增加。阴性、5%、10%及25%阳性水平,未经校正ES探针的计数结果与理论值差异有统计学意义(P〈0.05);50%及90%阳性水平,未经校正ES探针的计数结果与理论值差异无统计学意义(P〉0.05)。校正后ES探针的计数结果与理论值差异无统计学意义(P〉0.05)。结论对荧光原位杂交信号表现为1R1G1F的结果进行校正,能在一定程度上消除信号叠加所造成的假阳性,从而为低阳性水平标本提供更为可靠的结果。 Objective To explore the effect of false positive signals during detection of BCR/ABL fusion gene by fluorescence in situ hybridization (FISH), and develop a method for calibration. Methods Normal specimens were mixed with BCR/ABL positive specimens in which presented signal pattern of 1-red- 2-green-l-fusion (1R2G1F) using dual color dual fusion (DCDF) probes and 1-red-l-green-l-fusion (1R1GIF) using extra signal (ES) probes in different proportions. Mixed samples were detected using DCDF and ES probes. Results of DCDF probes, ES probe before calibration, ES probes after calibration and theoretical results were compared by binomial distribution in different proportions. Results The rate of false positive signals has risen with increase of negative rate. A significant difference was found between theoretical proportion and results without calibration in negative level, 5%, 10% and 25% positive level ( P〈0.05). There was no significant difference between theoretical proportion and results without calibration in 50% and 90% positive level (P〉0.05). Also there was no significant difference between theoretical proportion and calibrated results (P〉 0. 05). Conclusion Calibration of FISH result can delimitate the effect of false positives, and can provide more reliable results in cases with low level positive rates.
出处 《中华医学遗传学杂志》 CAS CSCD 北大核心 2016年第1期22-25,共4页 Chinese Journal of Medical Genetics
基金 广东省科技计划项目(2014A020212694) 广东省医学科研基金项目(A2015565) 广州市医药卫生科技项目重点项目(20121A021005)
关键词 荧光原位杂交 假阳性结果校正 BCR/ABL融合基因 Fluorescence in situ hybridization False positive result calibration BCR/ABL fusiongene
  • 相关文献

参考文献13

  • 1Dewatd GW, Schad CR, Christensen ER, et al. The application of fluorescent in situ hybridization to detect Mbcr/abl fusion in variant Ph chromosomes in Cytogenet, 1993, 71 ( 1 ) 90196-S. CML and ALL[J]. Cancer Genet 7-14. DOI: 10. 1016/0165-4608 (93).
  • 2Froneillo MC, Mallei L, Cantonetti M, et al. FISH analysis for CML monitoring? [J]. Ann Hematol, 1996, 73(3).. 113-119. DOI: 10. l182/asheducation-2015.1. 257.
  • 3Chase A, Grand F, Zhang JG, et al. Factors influencing the false positive and negative rates oc BCR-ABL fluorescence in situ hybridization[J]. Genes Chromosomes Cancer, 1997, 18 (4) : 246-253. DOI: 10. 1002/(SICI)1098-2264(199704)18.
  • 4Dewald GW, Juneau AL, Schad CR, et al. Cytogenetic and molecular genetic methods for diagnosis and treatment response in chronic granulocytic leukemia[J]. Cancer Genet Cytogenet, 1997, 94(1) : 59-66. DOI:10. 1016/$0165-4608(96)00292-0.
  • 5Garcia-Isidoro M, Tabernero MD, Garcia JL, et al. Detection ofthe Mbcr/abl translocation in chronic myeloid leukemia by fluorescence in situ hybridization: comparison with conventional eytogeneties and implications for minimal residual disease detection[J]. Hum Pathol, 1997, 28(2): 154-159. DOI: 10. 1016/S0046-8177(97)90099-X.
  • 6Werner M, Ewig M, Nasarek A, et al. Value of fluorescence in situ hybridization for detecting the bcr/abl gene fusion in interphase cells of routine bone marrow specimens[J]. Diagn MolPathol, 1997, 6(5) 282-287. DOI /I0. I097/00019606- 199710000-00006.
  • 7Vaz de Campos MG, Montesano FT, Rodrigues MM, et al. Clinical implications of der(9q) deletions detected through dual- fusion fluorescence in situ hybridization in patients with chronic myeloid leukemia[J]. Cancer Genet Cytogenet, 2007, 178 (1) : 49-56. DOI:/ 10. 1016/j. cancergencyto. 2007.06. 013.
  • 8Dewald GW, Wyatt WA, Juneau AL, et al. Highly sensitive fluorescence in situ hybridization method to detect double BCR/ ABL fusion and monitor response to therapy in chronic myeloid leukemia[J]. Blood, 1998, 91(9): 33573365.
  • 9Lee YK, Kim YR, Min HC, et al. Deletion of any part of the BCR or ABL gene on the derivative chromosome 9 is a poor prognostic marker in chronic myelogenous leukernia[J]. Cancer Genet Cytogenet, 2006, 166 (1): 65-73. DOI: 10. 1016/j. cancergencyto. 2005.08. 028.
  • 10Zagaria A, Anelli L, Albano F, et al. Molecular cytogenetic characterization o deletions on der (9) in chronic myelocytic !eukemia[J]. Cancer Genet Cytogenet, 2006, 167(2): 97-102. DOI: 10. 1016/j. cancergencyto. 2006.01. 011.

二级参考文献23

  • 1吴炜,薛永权,吴亚芳,潘金兰,沈娟.Ph染色体阳性慢性粒细胞白血病衍生9号染色体缺失的FISH研究[J].中华血液学杂志,2006,27(3):183-186. 被引量:12
  • 2钱思轩,李建勇,潘金兰,吴汉新,仇海荣,薛永权.荧光原位杂交技术在异性间造血干细胞移植后Ph阳性白血病的检测意义[J].中华内科杂志,2006,45(3):234-236. 被引量:9
  • 3戴海萍,薛永权,潘金兰,吴亚芳,张俊.1例伴有t(9;22)和ins(3;8)的慢性粒细胞白血病的临床和实验研究[J].实用临床医药杂志,2006,10(5):13-15. 被引量:1
  • 4Kalidas M, Kantarjian H, Talpaz M. Chronic myelogenous leukemia. JAMA,2001 ;286:895 - 898
  • 5Morel F, Ka C, Le Bris MJ, et al. Deletion of the 5' ABL region in Philadelphia chromosome positive chronic myeloid leukemia: frequency, origin and prognosis. Leuk Lymphoma, 2003 ; 44 : 1333 - 1338
  • 6Quintas-Cardama A, Kantarjian H, Talpaz M, et al. Imatinib mesylate therapy may overcome the poor prognostic significance of deletions of derivative chromosome 9 in patients with chronic myelogenous leukemia. Blood, 2005 ; 105 : 2281 -2286
  • 7Cohen N, Rozenfeld-Granot G, Hardan I, et al. Subgroup of patients with Philadelphia-positive chronic myeloganous leukemia characterized by a deletion of 9q proximal to ABL gane: expression profiling , resistance to interferon therapy , and poor prognosis . Cancer Genet Cytogenet, 2001 ; 128 : 114 - 119
  • 8Huntly B J, Reid AG, Bench AJ, et al. Deletions of the derivative chromosome 9 occur at the time of the Philadelphia translocation and provide a powerful and independent prognostic factor in chronic myeloid leukemia. Blood, 2001 ;98:1732 - 1738
  • 9Kolomietz E, Al-Maghrabi J, Brennan S, et al. Primary chromosomal rearrangements of leukemia are frequently accompanied by extensive submicroscopic deletions and may lead to altered prognosis. Blood, 2001; 97:3581 -3588
  • 10Garcia-Isidoro M, Tabernero MD, Garcia JL, et al. Detection of the Mbcr/abl translocation in chronic myeloid leukemia by fluorescence in situ hybridization: comparison with conventional eytogenetics and implications for minimal residual disease detection. Hum Pathol, 1997, 28:154-159.

共引文献12

同被引文献8

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部